Skip to content

Category Archives: Drug eluting stents

Move a device idea from the research phase to the market > Massachusetts medical device industry > Industry-specific support > Innovation Index of the Massachusetts Economy > Massachusetts Biomedical Initiatives > Dow Jones VentureSource > Massachusetts Technology Collaborative’s John Adams Innovation Institute > Worcester business incubators

Wednesday, February 13, 2008

Is Massachusetts a Medtech hub that benefits from industry that has developed there close to all the universities? Is the infrastructure for both the creation of device ideas and the development of device ideas unique to the state of Massachusetts? Why can medical device companies gain a foothold in Massachusetts that they cannot gain elsewhere?

IIP […]

Filed in Massachusetts medical device industry, BioVentures Investors, Medical device bill, Crescent Innovations Inc, Polymer injected into the body to reduce inflammation, TMJ pain treatment, AcroMIS LLC, Industry-specific support, Mount Auburn Hospital, McLean Hospital, Schepens Eye Research Institute, Spaulding Rehabilitation Hospital, Medical device business incubators, VA Boston, Entegrion's Stasilon, Wound care, Move a device idea from the research phase to the marke, Corporate partnerships, Innovation Index of the Massachusetts Economy, Massachusetts Biomedical Initiatives, Worcester business incubators, John Adams Innovation Institute, Angel groups, Detect the nuclei of atoms, Plastics injection molding, Nypro Inc, HydroCision Inc, Water-jet tools for surgeons, Nuclear resonance technology, SIV Technologies Inc, Massachusetts General Hospital, Massachusetts Eye and Ear Infirmary, Innovative technology, Start-up companies, Endoscopy Endoscopic, Boston Scientific, Venture Capital Financing, Initial Public Offering IPO, Food and Drug Administration FDA, Innovative products, Flexible endoscope, Laparoscopy Laparoscopic, Disclosing new technology and innovations, Medical Universities Research Institutes Med Societies, New product development, Endovascular stent graft, Entrepreneurs and investors, Medical Device Company, Forsyth Institute, Dana-Farber Cancer Institute, Harvard Pilgrim Health Care, Joslin Diabetes Center, Immune Disease Institute, Judge Baker Children's Center, Children's Hospital Boston, Cambridge Health Alliance, Drug eluting stents, Investigational device, Boston University Medical Center, US Healthcare is the largest industry in the United Sta, Brigham and Women's Hospital, Harvard Medical School, Medical Device Development | Comments (0)

Biosensors International Group > Receives CE Mark Approval for its BioMatrix Drug-Eluting Coronary Stent System > BioMatrix and NOBORI drug-eluting stents > Stents incorporate a biodegradable polymer coating together with an immunosuppressive drug

Saturday, January 19, 2008

Will BioMatrix provide a valuable alternative to the drug-eluting stents currently available to interventional cardiologists? Is the three-year follow-up data released at the Transcatheter Cardiovascular Therapeutics Conference showing BioMatrix’s superior results in terms of safety and clinical effectiveness? Will the increasing complexity of worldwide regulatory requirements make it more difficult in the future to introduce […]

Filed in PLA polymer fully degrades into water and carbon dioxid, Leaving in place a biocompatible stent surface, Drug has a higher lipophilic and hydrophobic profile, Immunosuppressive and anti-inflammatory properties, NOBORI drug-eluting stent system, Polymer coated onto the outer abluminal side of the ste, Drug to be released to targeted tissue, Transcatheter Cardiovascular Therapeutics Conference, Siegburg Heart Center, Eberhard Grube, Three separate drug-eluting stent programs, Terumo Corporation, Biolimus A9 biodegradable polymer and advanced stent de, Biosensors International Group, Medical Device Company, Efficacy, Medical Universities Research Institutes Med Societies, BioMatrix, Axxion, BioMatrix clinical trial program, Drug eluting stents, Licensed aspects of its drug-eluting stent technology t, BioMatrixFreedom polymer-free drug-eluting stent, Endoluminal Endolumenal Hollow Vessel | Comments (0)